Annual Total Liabilities
$12.74 M
-$4.69 M-26.90%
01 December 2023
Summary:
Plus Therapeutics annual total liabilities is currently $12.74 million, with the most recent change of -$4.69 million (-26.90%) on 01 December 2023. During the last 3 years, it has risen by +$3.66 million (+40.36%). PSTV annual total liabilities is now -71.33% below its all-time high of $44.42 million, reached on 31 December 2014.PSTV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$12.15 M
-$6.68 M-35.49%
01 September 2024
Summary:
Plus Therapeutics quarterly total liabilities is currently $12.15 million, with the most recent change of -$6.68 million (-35.49%) on 01 September 2024. Over the past year, it has dropped by -$584.00 thousand (-4.59%). PSTV quarterly total liabilities is now -79.83% below its all-time high of $60.24 million, reached on 31 March 2015.PSTV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -4.6% |
| 3 y3 years | +40.4% | +21.6% |
| 5 y5 years | -32.1% | -52.5% |
PSTV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.9% | +40.4% | -35.5% | +23.1% |
| 5 y | 5 years | -42.3% | +40.4% | -52.5% | +37.7% |
| alltime | all time | -71.3% | +1296.5% | -79.8% | +357.0% |
Plus Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.15 M(-35.5%) |
| June 2024 | - | $18.84 M(+80.1%) |
| Mar 2024 | - | $10.46 M(-17.9%) |
| Dec 2023 | $12.74 M(-26.9%) | $12.74 M(+19.5%) |
| Sept 2023 | - | $10.66 M(-7.6%) |
| June 2023 | - | $11.54 M(-11.0%) |
| Mar 2023 | - | $12.96 M(-25.6%) |
| Dec 2022 | $17.42 M(+56.3%) | $17.42 M(+48.9%) |
| Sept 2022 | - | $11.70 M(+0.9%) |
| June 2022 | - | $11.59 M(+17.4%) |
| Mar 2022 | - | $9.87 M(-11.4%) |
| Dec 2021 | $11.14 M(+22.8%) | $11.14 M(+11.5%) |
| Sept 2021 | - | $9.99 M(+12.4%) |
| June 2021 | - | $8.89 M(+0.7%) |
| Mar 2021 | - | $8.82 M(-2.8%) |
| Dec 2020 | $9.07 M(-58.9%) | $9.07 M(+0.5%) |
| Sept 2020 | - | $9.03 M(-14.8%) |
| June 2020 | - | $10.60 M(-49.2%) |
| Mar 2020 | - | $20.88 M(-5.4%) |
| Dec 2019 | $22.07 M(+17.6%) | $22.07 M(-13.6%) |
| Sept 2019 | - | $25.55 M(+68.6%) |
| June 2019 | - | $15.16 M(-27.0%) |
| Mar 2019 | - | $20.76 M(+10.6%) |
| Dec 2018 | $18.77 M(+0.8%) | $18.77 M(-3.2%) |
| Sept 2018 | - | $19.39 M(+8.2%) |
| June 2018 | - | $17.93 M(-1.3%) |
| Mar 2018 | - | $18.16 M(-2.4%) |
| Dec 2017 | $18.61 M(-21.2%) | $18.61 M(-0.1%) |
| Sept 2017 | - | $18.63 M(-12.3%) |
| June 2017 | - | $21.25 M(-5.2%) |
| Mar 2017 | - | $22.41 M(-5.1%) |
| Dec 2016 | $23.62 M(-7.3%) | $23.62 M(+1.9%) |
| Sept 2016 | - | $23.17 M(-3.3%) |
| June 2016 | - | $23.96 M(-4.8%) |
| Mar 2016 | - | $25.17 M(-1.3%) |
| Dec 2015 | $25.49 M(-42.6%) | $25.49 M(-31.9%) |
| Sept 2015 | - | $37.45 M(-15.4%) |
| June 2015 | - | $44.26 M(-26.5%) |
| Mar 2015 | - | $60.24 M(+35.6%) |
| Dec 2014 | $44.42 M(+14.1%) | $44.42 M(+24.8%) |
| Sept 2014 | - | $35.61 M(-3.9%) |
| June 2014 | - | $37.06 M(+0.1%) |
| Mar 2014 | - | $37.02 M(-4.9%) |
| Dec 2013 | $38.93 M(+5.8%) | $38.93 M(+1.3%) |
| Sept 2013 | - | $38.41 M(-0.2%) |
| June 2013 | - | $38.50 M(+24.2%) |
| Mar 2013 | - | $31.00 M(-15.8%) |
| Dec 2012 | $36.80 M | $36.80 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $41.74 M(+4.5%) |
| June 2012 | - | $39.96 M(-5.4%) |
| Mar 2012 | - | $42.25 M(+1.6%) |
| Dec 2011 | $41.59 M(-4.3%) | $41.59 M(-4.7%) |
| Sept 2011 | - | $43.64 M(+13.0%) |
| June 2011 | - | $38.62 M(-14.0%) |
| Mar 2011 | - | $44.88 M(+3.2%) |
| Dec 2010 | $43.47 M(+53.0%) | $43.47 M(+11.9%) |
| Sept 2010 | - | $38.86 M(+6.8%) |
| June 2010 | - | $36.39 M(+60.2%) |
| Mar 2010 | - | $22.71 M(-20.1%) |
| Dec 2009 | $28.41 M(-14.8%) | $28.41 M(+7.5%) |
| Sept 2009 | - | $26.42 M(-0.5%) |
| June 2009 | - | $26.56 M(-20.4%) |
| Mar 2009 | - | $33.38 M(+0.2%) |
| Dec 2008 | $33.33 M(+7.8%) | $33.33 M(+15.0%) |
| Sept 2008 | - | $28.98 M(-0.5%) |
| June 2008 | - | $29.13 M(-1.1%) |
| Mar 2008 | - | $29.44 M(-4.7%) |
| Dec 2007 | $30.91 M(-13.4%) | $30.91 M(+7.6%) |
| Sept 2007 | - | $28.71 M(-11.1%) |
| June 2007 | - | $32.31 M(-7.8%) |
| Mar 2007 | - | $35.05 M(-1.8%) |
| Dec 2006 | $35.68 M(+3.7%) | $35.68 M(-12.6%) |
| Sept 2006 | - | $40.81 M(-0.3%) |
| June 2006 | - | $40.93 M(-9.0%) |
| Mar 2006 | - | $44.98 M(+30.8%) |
| Dec 2005 | $34.40 M(+172.2%) | $34.40 M(+103.8%) |
| Sept 2005 | - | $16.88 M(-17.2%) |
| June 2005 | - | $20.37 M(+63.7%) |
| Mar 2005 | - | $12.44 M(-1.5%) |
| Dec 2004 | $12.64 M(-4.1%) | $12.64 M(-1.6%) |
| Sept 2004 | - | $12.84 M(-30.0%) |
| June 2004 | - | $18.35 M(+51.0%) |
| Mar 2004 | - | $12.15 M(-7.8%) |
| Dec 2003 | $13.18 M(-1.1%) | $13.18 M(-0.8%) |
| Sept 2003 | - | $13.28 M(+12.4%) |
| June 2003 | - | $11.82 M(-2.6%) |
| Mar 2003 | - | $12.14 M(-8.9%) |
| Dec 2002 | $13.32 M(+186.1%) | $13.32 M(+5.1%) |
| Sept 2002 | - | $12.68 M(+196.5%) |
| June 2002 | - | $4.28 M(-5.5%) |
| Mar 2002 | - | $4.52 M(-2.9%) |
| Dec 2001 | $4.66 M(+58.7%) | $4.66 M(+75.1%) |
| Sept 2001 | - | $2.66 M(-4.7%) |
| June 2001 | - | $2.79 M |
| Dec 2000 | $2.93 M(-75.0%) | - |
| Dec 1999 | $11.72 M(+1185.3%) | - |
| Dec 1998 | $912.00 K | - |
FAQ
- What is Plus Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Plus Therapeutics?
- What is Plus Therapeutics quarterly total liabilities year-on-year change?
What is Plus Therapeutics annual total liabilities?
The current annual total liabilities of PSTV is $12.74 M
What is the all time high annual total liabilities for Plus Therapeutics?
Plus Therapeutics all-time high annual total liabilities is $44.42 M
What is Plus Therapeutics quarterly total liabilities?
The current quarterly total liabilities of PSTV is $12.15 M
What is the all time high quarterly total liabilities for Plus Therapeutics?
Plus Therapeutics all-time high quarterly total liabilities is $60.24 M
What is Plus Therapeutics quarterly total liabilities year-on-year change?
Over the past year, PSTV quarterly total liabilities has changed by -$584.00 K (-4.59%)